HPHA.DE Forward P/E

The Forward P/E of Heidelberg Pharma AG (HPHA.DE) is N/A.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

HPHA.DE Forward P/E - Peers Comparison

Ticker	Name	Value
ORPHA.CO	Orphazyme A/S	16.18
BINV.ST	BioInvent International AB	3.35
BVXP.L	Bioventix PLC	1714.25
OSE.PA	OSE Immunotherapeutics SA	16.16
ORY.MC	Oryzon Genomics SA	149.90
XBRANE.ST	Xbrane Biopharma AB	2.89
ALQGC.PA	Quantum Genomics SA	0.02